We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Six hospital and pharmacy groups have submitted a letter to HHS Secretary Xavier Becerra objecting to drugmakers eliminating 340B drug discounts to contract pharmacies and calling on the department to take a more aggressive stance against such actions, including civil fines. Read More
The EU has made clear that it will set its sights on obtaining additional doses of Pfizer/BioNTech’s and Moderna’s mRNA-based COVID-19 vaccines, opting to pass on pursuing more doses of AstraZeneca (AZ)’s adenoviral-vector vaccine. Read More
Vertex Pharmaceuticals has paid $900 million to CRISPR Therapeutics, a Swiss-American biotech, to amend their collaborative agreement, entitling Vertex to more than half of the profits from future sales of CTX001, their investigational gene therapy for sickle cell disease (SCD) and transfusion-dependent beta thalassemia (TDT). Read More
The Russian Direct Investment Fund (RDIF), which funded Sputnik V’s development, said the vaccine has now been authorized in more than 60 countries. Read More
The EU has exercised its option to purchase 100 million additional doses of Pfizer/BioNTech’s two-dose COVID-19 vaccine, putting the trade bloc in line to receive 600 million shots in total this year as it clamors for additional supplies to boost its vaccination efforts. Read More
A bench trial in a 2019 lawsuit by Ferring Pharmaceuticals against generic drug giant Lupin Pharmaceuticals gets under way today, with Ferring alleging that the generic drugmaker sought to infringe on a patent for its prescription drug Clenpiq, a drinkable bowel cleanser. Read More
Novartis has agreed to help manufacture Roche’s blockbuster rheumatoid arthritis drug Actemra (tocilizumab) as a COVID-19 treatment — in another pact that offers the company’s manufacturing might to help produce a rival’s COVID-19 therapies or vaccines. Read More
The ranks of the top-earning contract research organizations (CROs) continued to shift this week as Thermo Fisher Scientific announced it will acquire PPD, one of the industry’s largest CROs, for $17.4 billion in cash plus the assumption of about $3.5 billion of net debt. Read More
Earlier this week, Sanofi announced that it will invest $476 million in a multi-vaccine manufacturing facility in Singapore to mass-produce vaccines for the Asian market. Read More